Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed .

Clinical trial NCT04099303 · COMPLETED

Trial details

NCT number: NCT04099303
Sponsor: CanSino Biologics Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diphtheria Tetanus Pertussis

Start date: 2020-04-28
Primary completion: 2021-10-27
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.